Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hematologic Neoplasms × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Pancreatic Neoplasms 9 Breast Neoplasms 7 Prostatic Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Multiple Myeloma 3 Melanoma 3 COVID-19 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Recurrence 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Leukemia 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma of Lung 2 Urologic Diseases 1 Untreated Resectable Pancreatic Adenocarcinoma 1 Sarcoma 1 Resectable Localized Prostate Cancer 1 Refractory or Relapsed Solid Tumors 1 Radiation-induced Oral Mucositis 1 Prostate Cancer Recurrent 1

Interventions

Cyclophosphamide 65 fludarabine 59 Tacrolimus 40 fludarabine phosphate 39 Whole-Body Irradiation 35 Mycophenolic Acid 30 Busulfan 29 Melphalan 24 thymoglobulin 20 Antilymphocyte Serum 20 Thiotepa 19 Methotrexate 19 Standard of Care 18 Stem Cell Transplantation 17 Practice Guidelines as Topic 16 Granulocyte Colony-Stimulating Factor 15 Rituximab 14 Surveys and Questionnaires 12 Sirolimus 12 Filgrastim 11 Blood Specimen Collection 11 venetoclax 9 Peripheral Blood Stem Cell Transplantation 9 Mesna 9 Interviews as Topic 9 Bortezomib 9 Hematopoietic Stem Cell Transplantation 8 Exercise 8 Cytarabine 8 Cyclosporine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡